前列腺素E1对体内自体标记血小板在人动脉粥样硬化病变上沉积的影响。
Effect of prostaglandin E1 on deposition of autologous labelled platelets onto human atherosclerotic lesions in vivo.
作者信息
Sinzinger H, O'Grady J, Fitscha P
机构信息
Department of Nuclear Medicine, University of Vienna, Austria.
出版信息
Postgrad Med J. 1987 Apr;63(738):245-7. doi: 10.1136/pgmj.63.738.245.
Abstract
The effects of infusions of prostaglandin E1 (PGE1) on platelet deposition at atherosclerotic sites in vivo in man have been examined. Thirteen patients with atherosclerotic vascular disease received intravenous PGE1 25 mg/kg/min for 6 hours daily for 5 days. Prostaglandin E1 had no effect on platelet uptake at atherosclerotic sites but prolonged platelet half-life significantly (P less than 0.001).
摘要
已对前列腺素E1（PGE1）输注对人体体内动脉粥样硬化部位血小板沉积的影响进行了研究。13例动脉粥样硬化性血管疾病患者每天静脉输注PGE1，剂量为25毫克/千克/分钟，持续6小时，共5天。前列腺素E1对动脉粥样硬化部位的血小板摄取没有影响，但显著延长了血小板半衰期（P<0.001）。
相似文献
1
Effect of prostaglandin E1 on deposition of autologous labelled platelets onto human atherosclerotic lesions in vivo.前列腺素E1对体内自体标记血小板在人动脉粥样硬化病变上沉积的影响。
Postgrad Med J. 1987 Apr;63(738):245-7. doi: 10.1136/pgmj.63.738.245.
2
Comparable effect of prostaglandin E1 in decreasing in vivo platelet deposition on human lesion sites after intravenous and intraarterial application.静脉内和动脉内应用后，前列腺素E1在减少人体损伤部位体内血小板沉积方面的效果相当。
Thromb Res. 1988 Jun 15;50(6):749-55. doi: 10.1016/0049-3848(88)90335-0.
3
Recovery and survival in vivo of platelet concentrates prepared with prostaglandin E1.用前列腺素E1制备的浓缩血小板在体内的恢复与存活情况。
Transfusion. 1988 Jan-Feb;28(1):56-8. doi: 10.1046/j.1537-2995.1988.28188127954.x.
4
In vivo modulation of platelet deposition on human atherosclerotic lesions by various antiaggregatory prostaglandins.多种抗聚集前列腺素对人动脉粥样硬化病变处血小板沉积的体内调节作用。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1988;115(4):443-6.
5
6
7
Experimental assessment of thrombogenicity in vascular prostheses before and during prostaglandin E1 treatment.前列腺素E1治疗前后血管假体血栓形成性的实验评估。
Eur J Vasc Surg. 1993 Sep;7(5):493-9. doi: 10.1016/s0950-821x(05)80359-7.
8
[Pharmacologic concepts for clinical use of prostaglandin E1].[前列腺素E1临床应用的药理学概念]
Vasa Suppl. 1991;33:335-6.
9
Potentiation of alpha-naphthyl thiourea-induced lung injury by prostaglandin E1 and platelet depletion.前列腺素E1和血小板耗竭对α-萘基硫脲诱导的肺损伤的增强作用。
Lab Invest. 1984 Jun;50(6):703-10.
10
Effects of prostaglandin E1 metabolites on the induction of arterial thromboresistance.前列腺素E1代谢产物对动脉血栓抵抗诱导的影响。
Prostaglandins Other Lipid Mediat. 1998 Apr;55(5-6):265-75. doi: 10.1016/s0090-6980(98)00025-2.
引用本文的文献
1
Horizontal acquisition of a patchwork Calvin cycle by symbiotic and free-living Campylobacterota (formerly Epsilonproteobacteria).共生和自由生活的弯曲杆菌门（原 ε 变形菌门）通过水平获得拼凑的卡尔文循环。
ISME J. 2020 Jan;14(1):104-122. doi: 10.1038/s41396-019-0508-7. Epub 2019 Sep 27.
2
Stabilization of endothelial lining and decrease in circulating endothelial cells--one mechanism underlying the clinical action of PGE1?内皮衬里的稳定及循环内皮细胞数量的减少——PGE1临床作用的潜在机制之一？
Br J Clin Pharmacol. 1988 Jun;25(6):775-6. doi: 10.1111/j.1365-2125.1988.tb05268.x.
本文引用的文献
1
Effect of intra-arterial infusion of PGE1 in patients with severe ischemia of lower extremity.前列地尔动脉内灌注治疗下肢严重缺血患者的疗效
J Cardiovasc Surg (Torino). 1980 Mar-Apr;21(2):185-92.
2
Preliminary experience with prostaglandins E1 and I2 in peripheral vascular disease.
Surgery. 1980 Dec;88(6):826-32.
3
Clinical observations with intravenous prostaglandin E1 in peripheral vascular disease.静脉注射前列腺素E1治疗周围血管疾病的临床观察
J Med Soc N J. 1982 Dec;79(13):985-7.
4
The intrainfusion platelet rebound during and following PGE1-infusion is faster and more intensive than that with PGI2.输注PGE1期间及之后的输注内血小板反弹比输注PGI2时更快且更强烈。
Prostaglandins Leukot Med. 1984 Mar;13(3):281-8. doi: 10.1016/0262-1746(84)90041-6.
5
A simple and safe technique for sterile autologous platelet labelling using "Monovette" vials.一种使用“Monovette”瓶进行无菌自体血小板标记的简单安全技术。
Eur J Nucl Med. 1984;9(7):320-2. doi: 10.1007/BF00276462.
6
Efficacy of prostaglandin E1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease. Results of a prospective randomized, double-blind, multicenter clinical trial.前列腺素E1治疗外周血管闭塞性疾病继发下肢缺血性溃疡的疗效。一项前瞻性随机双盲多中心临床试验的结果
J Vasc Surg. 1984 Jan;1(1):160-70. doi: 10.1067/mva.1984.avs0010160.
7
Clinical pharmacology and potential of prostacyclin.前列环素的临床药理学及潜力
Br Med Bull. 1983 Jul;39(3):281-4. doi: 10.1093/oxfordjournals.bmb.a071834.
8
Detrimental effect of high-dose prostaglandin E1 in the treatment of ischemic ulcers.大剂量前列腺素E1治疗缺血性溃疡的有害作用。
Surgery. 1983 Jun;93(6):839-42.
9
Epoprostenol and platelet deposition in atherosclerosis.依前列醇与动脉粥样硬化中的血小板沉积
Lancet. 1984 Apr 21;1(8382):905-6. doi: 10.1016/s0140-6736(84)91363-1.
10
Epoprostenol (prostacyclin) decreases platelet deposition on vascular prosthetic grafts.依前列醇（前列环素）可减少血小板在血管人工移植物上的沉积。
Lancet. 1983 Jun 4;1(8336):1275-6. doi: 10.1016/s0140-6736(83)92721-6.
Zotero 插件